Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Liabilities and Shareholders Equity (2024 - 2025)

Hinge Health (HNGE) has disclosed Liabilities and Shareholders Equity for 2 consecutive years, with $744.8 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 10.62% to $744.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.9 billion through Dec 2025, up 327.99% year-over-year, with the annual reading at $744.8 million for FY2025, 10.62% up from the prior year.
  • Liabilities and Shareholders Equity hit $744.8 million in Q4 2025 for Hinge Health, down from $769.8 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $769.8 million in Q3 2025 to a low of $673.3 million in Q4 2024.